Literature DB >> 25246918

Semen problem in beta-thalassemia: an interesting focus on tropical reproductive science and hematology.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2012        PMID: 25246918      PMCID: PMC4169690     

Source DB:  PubMed          Journal:  Iran J Reprod Med        ISSN: 1680-6433


× No keyword cloud information.
Dear Editor, The problem of congenital hemoglobin disorder is common in tropical Asia. In tropical Southeast Asian countries, very high prevalence of thalassemia disorder especially for beta thalassemia is observed. This tropical hematological problem affects millions of population and cause several health disorders. Of interest, the issue of reproductive health impairment of the population with beta thalassemia disorder is not well mentioned. Here, the author tried to summarize some important information on the semen problem in beta-thalassemia. In beta-thalassemia major, poor semen quality is observed. It is noted that most patients have “hypogonadotropic hypogonadism state, impairment fertility and growth retardation (1).” Jensen et al proposed that “The causation is multi-factorial, with iron deposition in the pituitary gland resulting from life-long dependence on blood transfusions being a major factor (2).” It is evidenced that the sperm DNA damage is due to oxidative stress from iron overload (3-4). Nevertheless, it is reported that the spermatogenesis in the patients are also suppressed by chelation therapy, desferrioxamine (5). The degree of sperm DNA damage is interestingly high in the case with low ferritin level (5-6). It seems that the exacts mechanism of semen problem in beta thalassemia patient is very complex and relating to unknown disturbance of iron metabolism impairment in the patients.
  6 in total

1.  Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine.

Authors:  V De Sanctis; G Borsari; S Brachi; M Govoni; G Carandina
Journal:  Georgian Med News       Date:  2008-03

2.  Sperm concentrations and quality in beta-thalassaemia major.

Authors:  C E Jensen; A Abdel-Gadir; C Cox; S M Tuck; B Wonke
Journal:  Int J Androl       Date:  1996-12

3.  Antioxidant capacity in seminal plasma of transfusion-dependent beta-thalassemic patients.

Authors:  A Carpino; P Tarantino; V Rago; V De Sanctis; L Siciliano
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-03       Impact factor: 2.949

4.  Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload.

Authors:  Doreen Perera; Arnold Pizzey; Alastair Campbell; Maurice Katz; John Porter; Mary Petrou; D S Irvine; Ratna Chatterjee
Journal:  Hum Reprod       Date:  2002-07       Impact factor: 6.918

5.  Evaluation of semen quality, endocrine profile and hypothalamus-pituitary-testis axis in male patients with homozygous beta-thalassemia major.

Authors:  Mohammad Reza Safarinejad
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

6.  Spermatozoal DNA damage in patients with B thalassaemia syndromes.

Authors:  Vincenzo De Sanctis; Doreen Perera; Maurice Katz; Monica Fortini; Maria Rita Gamberini
Journal:  Pediatr Endocrinol Rev       Date:  2008-10
  6 in total
  1 in total

1.  Indicators of male fertility potential in adult patients with beta-thalassemia major: a comparative study between patients undergone allogeneic stem cell transplantation and transfusion-dependent patients.

Authors:  Tahereh Rostami; Mohammad Amir Mohammadifard; Shahla Ansari; Azadeh Kiumarsi; Nasrollah Maleki; Amir Kasaeian; Fatemeh Aghamahdi; Soroush Rad; Ardeshir Ghavamzadeh
Journal:  Fertil Res Pract       Date:  2020-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.